EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making

Christina M Mansour, Long-Co L Nguyen, Fabio Sagebin, Antonio H Frangieh iD

Journal of Clinical Medicine · 17.03.2026 · 15 (6) · 2269

DOI: 10.3390/jcm15062269 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.03.2026. Verfasst von Christina M Mansour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The landscape surrounding aortic stenosis continues to evolve as transcatheter aortic valve replacement (TAVR) is increasingly performed in younger and lower-risk patients who are likely to outlive their index prosthesis. With the rapid evolution in management of aortic stenosis, treatment has shifted from a single-procedure paradigm toward a lifetime strategy that anticipates future reinterventions. Therefore, having a foundational understanding and a thoughtful strategy when selecting the index procedure is paramount.

Objectives

The objectives of this review article are to review contemporary evidence and provide a structured framework for lifetime management of severe AS. We focus on optimizing index valve selection and planning durable, safe pathways for subsequent reinterventions.

Conclusions

Lifetime management of aortic stenosis requires a forward-looking, patient-centered Heart Team approach that extends beyond immediate procedural success. Strategic selection of the index valve intervention is crucial, and this is guided by anatomy, life expectancy, comorbidities, patient preference, and future reintervention feasibility. Together, these factors are essential to optimize long-term outcomes. As treatment paradigms continue to evolve, anticipatory planning and advanced simulation technologies will play an increasingly central role in delivering durable personalized care for patients with severe AS.

Schlagwörter

Stichwörter der Autor:innen

SAVRTAVRindex procedurelifetime managementvalve durability

Autor:innen und Institutionen

  • Mary & Steve Wen Cardiovascular Division, University of California Irvine, Irvine, CA 92697, USA.
  • Division of Cardiac Surgery, University of California Irvine, Irvine, CA 92697, USA.

ORCID-Profile: Antonio H Frangieh

Zitieren

APA

Mansour, C. M., Nguyen, L. L., Sagebin, F., & Frangieh, A. H. (2026). Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making. Journal of Clinical Medicine, 15(6), 2269. https://doi.org/10.3390/jcm15062269

Vancouver

Mansour CM, Nguyen LL, Sagebin F, Frangieh AH. Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making. Journal of Clinical Medicine. 2026;15(6):2269. doi:10.3390/jcm15062269

BibTeX
@article{Mansour2026,
  author = {Mansour, Christina M and Nguyen, Long-Co L and Sagebin, Fabio and Frangieh, Antonio H},
  title = {Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {2269},
  doi = {10.3390/jcm15062269}
}
Kostenlos starten →